Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Graphic Packaging
GPK
$3.35B
| $11.6M | 0.01% |
+832,754
| New | +$11.2M |
|
1302
Nektar Therapeutics
NKTR
$2.39B
| $11.6M | 0.01% |
21,803
+8,106
| +59% | +$4.06M |
|
1303
SiriusPoint
SPNT
$3.03B
| $11.6M | 0.01% |
1,127,167
+749,600
| +199% | +$8.02M |
|
|
SGI
1304
Somnigroup International
SGI
$14.4B
| $11.6M | 0.01% |
633,600
-292,800
| -32% | -$4.72M |
|
1305
Bassett Furniture
BSET
$169M
| $11.6M | 0.01% |
761,300
+23,884
| +3% | +$383K |
|
|
BPFH
1306
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $11.6M | 0.01% |
961,372
+164,700
| +21% | +$1.85M |
|
1307
Marchex
MCHX
$78M
| $11.5M | 0.01% |
2,456,112
+364,978
| +17% | +$1.74M |
|
|
HDS
1308
DELISTED
HD Supply Holdings, Inc.
HDS
| $11.5M | 0.01% |
286,200
-425,200
| -60% | -$18.2M |
|
|
SCS
1309
DELISTED
Steelcase
SCS
| $11.5M | 0.01% |
673,600
+143,000
| +27% | +$2.38M |
|
|
CNBKA
1310
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $11.5M | 0.01% |
131,001
+8,301
| +7% | +$727K |
|
|
PRGX
1311
DELISTED
PRGX Global, Inc.
PRGX
| $11.5M | 0.01% |
1,712,910
-1,990
| -0.1% | -$14.3K |
|
1312
Mesa Laboratories
MLAB
$551M
| $11.4M | 0.01% |
46,800
-7,100
| -13% | -$1.65M |
|
1313
Liberty Latin America Class C
LILAK
$1.69B
| $11.4M | 0.01% |
776,619
+464,242
| +149% | +$7.58M |
|
|
HF
1314
DELISTED
HFF Inc.
HF
| $11.4M | 0.01% |
250,600
+87,200
| +53% | +$3.99M |
|
1315
Amcor
AMCR
$21.2B
| $11.3M | 0.01% |
+198,932
| New | +$11M |
|
|
NOA
1316
North American Construction
NOA
$357M
| $11.3M | 0.01% |
1,044,600
+55,100
| +6% | +$641K |
|
|
TIVO
1317
DELISTED
Tivo Inc
TIVO
| $11.3M | 0.01% |
1,528,535
+1,413,035
| +1,223% | +$11.3M |
|
1318
AdvanSix
ASIX
$542M
| $11.3M | 0.01% |
460,800
+22,700
| +5% | +$637K |
|
|
ADAM
1319
Adamas Trust
ADAM
$777M
| $11.3M | 0.01% |
453,825
-15,250
| -3% | -$377K |
|
1320
Reinsurance Group of America
RGA
$15.5B
| $11.3M | 0.01% |
72,100
+61,100
| +555% | +$9.14M |
|
|
PTNR
1321
DELISTED
Partner Communications
PTNR
| $11.3M | 0.01% |
2,678,650
-3,000
| -0.1% | -$13.3K |
|
|
CVGW
1322
DELISTED
Calavo Growers
CVGW
| $11.2M | 0.01% |
116,200
-31,600
| -21% | -$2.95M |
|
1323
Ooma
OOMA
$601M
| $11.2M | 0.01% |
1,072,603
-34,400
| -3% | -$437K |
|
1324
Nomad Foods
NOMD
$1.77B
| $11.2M | 0.01% |
525,300
-69,700
| -12% | -$1.46M |
|
|
CHA
1325
DELISTED
China Telecom Corporation, LTD
CHA
| $11.2M | 0.01% |
224,113
-5,787
| -3% | -$297K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.